EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The association between coronavirus disease 2019 vaccination during pregnancy and neonatal health outcomes

Petra J Woestenberg iD, Veronique Y F Maas, Lieke C M Vissers, Nadia M B Oliveri, Agnes C Kant, Maud de Feijter

Pediatric Investigation · 2025

DOI: 10.1002/ped4.12456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Investigation, 2025. Verfasst von Petra J Woestenberg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Netherlands Pharmacovigilance Centre Lareb 's-Hertogenbosch the Netherlands. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Pregnant women have a higher risk of severe illness or complications due to a severe acute respiratory syndrome coronavirus 2 infection. To reduce these risks, pregnant women are advised to coronavirus disease 2019 (COVID‐19) vaccination. Continued monitoring of the safety of maternal COVID‐19 vaccination remains important.

Objective

To evaluate the association between maternal COVID‐19 vaccination and neonatal health.

Methods

Data from the Dutch Pregnancy Drug Register were used. In this prospective cohort study, pregnant women self‐reported COVID‐19 vaccination and neonatal health outcomes. We included women with a due date between January 15, 2021, and May 15, 2022, and a singleton live birth after at least 24 weeks gestation. Using log‐binomial regression analysis we studied the association between COVID‐19 vaccination during pregnancy and the health outcomes; small for gestational age (SGA), large for gestational age (LGA), and neonatal health problems. We corrected for potential confounders using inverse probability of treatment weighting.

Results

In total, 3655 participants were included (92.1% COVID‐19 vaccinated during pregnancy). Of all participants, 8.9% reported SGA, 11.1% reported LGA, and 16.4% reported neonatal health problems. Maternal COVID‐19 vaccination was not statistically significantly associated with SGA (adjusted prevalence ratio [aPR]: 0.90; 95% confidence interval [CI]: 0.59–1.36), LGA (aPR: 1.07; 95% CI: 0.70–1.63), or neonatal health problems (aPR: 0.84; 95% CI: 0.63–1.11).

Interpretation

This study indicates that COVID‐19 vaccination during pregnancy is not associated with self‐reported adverse neonatal health outcomes. These findings contribute to the growing body of evidence on the safety of COVID‐19 vaccination during pregnancy.

Schlagwörter

Stichwörter der Autor:innen

COVID‐19CohortLarge for gestational agePregnancySmall for gestational ageVaccination

Autor:innen und Institutionen

  • Netherlands Pharmacovigilance Centre Lareb 's-Hertogenbosch the Netherlands.
  • Department of Clinical Pharmacology and Toxicology Leiden University Medical Centre Leiden the Netherlands.

ORCID-Profile: Petra J Woestenberg

Zitieren

APA

Woestenberg, P. J., Maas, V. Y. F., Vissers, L. C. M., Oliveri, N. M. B., Kant, A. C., & de Feijter, M. (2025). The association between coronavirus disease 2019 vaccination during pregnancy and neonatal health outcomes. Pediatric Investigation. https://doi.org/10.1002/ped4.12456

Vancouver

Woestenberg PJ, Maas VYF, Vissers LCM, Oliveri NMB, Kant AC, de Feijter M. The association between coronavirus disease 2019 vaccination during pregnancy and neonatal health outcomes. Pediatric Investigation. 2025. doi:10.1002/ped4.12456

BibTeX
@article{Woestenberg2025,
  author = {Woestenberg, Petra J and Maas, Veronique Y F and Vissers, Lieke C M and Oliveri, Nadia M B and Kant, Agnes C and de Feijter, Maud},
  title = {The association between coronavirus disease 2019 vaccination during pregnancy and neonatal health outcomes},
  journal = {Pediatric Investigation},
  year = {2025},
  doi = {10.1002/ped4.12456}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche